Neopharm Israel
One of Israel's leading pharmaceutical companies. Markets medicines, equipment and advanced technologies to improve health and quality of life.
Neopharm Israel, one of the largest and leading pharmaceutical companies in Israel, provides medicines, treatment options and innovative solutions that strive to continuously improve the health and quality of life of people suffering from serious chronic diseases. The company operates in the fields of oncology, hematology, infectious diseases, autoimmune diseases, metabolic diseases, neurology, endocrinology, gastroenterology, hepatology and dermatology.
The home care division at Neopharm Israel is a unique therapeutic division that provides advanced medical services in patients' own homes, as an alternative to hospitalization. The division provides patients with medicines and innovative technologies, combined with nursing and advanced pharmacy services.
The Genmedix division at Neopharm Israel provides patients with medicinal products that are not registered or available in Israel.
The company's customers include HMOs, hospitals, pharmacies, laboratories and leading medical institutes, physicians, nurses and private customers.
A proven track record of almost 80 years of successful launches, a comprehensive range of services, a deep understanding of market and customer needs, professional relationships with decision-makers and adherence to the highest standards make Neopharm Israel the partner of choice for a long list of multinational companies seeking to establish or expand their activity in Israel.
We offer our business partners a full spectrum of services, including research, regulatory affairs, marketing, sales and trade, logistics and distribution, regulatory management and clinical trial management.
Pre-launch market analysis – we provide important medical insights and market research data, such as market potential assessments at the earliest stages of the marketing process.
Regulatory approval and registration of new medicines
The regulatory division at Neopharm Group headquarters, which comprises more than 15 professionals with extensive experience and an understanding of all the regulatory requirements of the Israeli Ministry of Health, provides regulatory services and close support for our business partners, including new submissions and registration, marketing approvals, variations, renewals, etc.
Scientific and medical knowledge and information
Our medical division provides professional scientific knowledge and medical information about our products, the competitors and the market in which they operate. The division also works to promote our products ethically and reliably, through thorough data review.
Fast market access
A deep understanding of the existing pathways for drug approval and registration in Israel enables us to ensure fast market access following FDA or EMA approval.
A proven track record of successful launches and rapid market penetration
Our well-established position in the pharmaceutical market, together with a deep understanding of the market and the long-term professional cooperation our team has developed with key stakeholders, strengthen product lifecycle strategies and help us achieve our business objectives.
Advanced marketing platforms
We specialize in formulating and executing marketing plans based on statistical data, extensive experience in the Israeli markets and the use of advanced, innovative marketing techniques. Our marketing teams include, among others, experienced and professional marketing managers and medical representatives with extensive sales experience who undergo appropriate training.